Sitemap - 2022 - FarmaKology’s Substack
FarmaKology-AI Identifies Patients at Risk of Diabetes
FarmaKology-New trial to allow pharmacists to prescribe medication
FarmaKology-A new mechanism of drug resistance discovered for breast cancer
FarmaKology-Lonza and Touchlight collaborate on end-to-end mRNA offering
FarmaKology-Amgen to acquire ChemoCentryx for $4 billion
FarmaKology-Shionogi aims to boost antibotic access in over 100 countries
FarmaKology-Omicron InfectionsWithout Vaccinations Provide Little Immunity
FarmaKology-Gene Therapy Could Treat Pitt-Hopkins Syndrome
FarmaKology-New Genomics Technology Could Power Gene Therapy in Oncology
FarmaKology-Popular nausea medications linked to increased stroke risk
FarmaKology-4th COVID vaccine dose offers “marginal benefits” in healthy adults
FarmaKology-Honoring Women Leadership in Pharmacy
FarmaKology-GSK announces independent Consumer Healthcare company
FarmaKology-Scientists discover how caffeine protects against cardiovascular disease
FarmaKology-Reuters Events : Pharma Predictions 2022-2027
FarmaKology-Researchers identify osteoarthritis 'pain pathway'
FarmaKology-Reuters Events Pharma: Customer Engagement Europe (May 24-25, London)
FarmaKology-Mutations in SARS-CoV-2 Omicron variant promote cell binding
FarmaKology-Viagra could be used to treat Alzheimer’s disease